Centiva Capital, LP - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$4,623,728
+1.7%
426,9370.0%0.10%
+2.0%
Q2 2023$4,546,879
+347.1%
426,937
+338.3%
0.10%
+300.0%
Q1 2023$1,017,023
-49.2%
97,416
-50.0%
0.02%
-10.7%
Q4 2022$2,002,872
+104.6%
194,832
+100.0%
0.03%
+55.6%
Q3 2022$979,000
-5.7%
97,416
-5.7%
0.02%
-28.0%
Q2 2022$1,038,000
+5.1%
103,250
+3.2%
0.02%
+31.6%
Q1 2022$988,000100,0000.02%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 718,701$7,790,6470.97%
BERKLEY W R CORP 1,119,638$12,125,6800.79%
First Trust Capital Management L.P. 1,106,378$11,993,0270.66%
COWEN AND COMPANY, LLC 679,393$7,364,5520.52%
Westchester Capital Management, LLC 1,390,000$15,053,7010.44%
METEORA CAPITAL, LLC 235,256$2,550,1520.44%
BCK CAPITAL MANAGEMENT LP 74,268$805,0580.41%
Exos TFP Holdings LLC 60,000$650,4000.35%
PERISCOPE CAPITAL INC. 250,000$2,709,9750.31%
FIR TREE CAPITAL MANAGEMENT LP 230,111$2,492,1020.26%
View complete list of BIOPLUS ACQUISITION CORP shareholders